Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.

MLA

Hu, Minghua, et al. “Loss of MiR-1258 Contributes to Carcinogenesis and Progression of Liver Cancer through Targeting CDC28 Protein Kinase Regulatory Subunit 1B.” Oncotarget, vol. 7, no. 28, July 2016, pp. 43419–31. EBSCOhost, https://doi.org/10.18632/oncotarget.9728.

APA

Hu, M., Wang, M., Lu, H., Wang, X., Fang, X., Wang, J., Ma, C., Chen, X., & Xia, H. (2016). Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B. Oncotarget, 7(28), 43419–43431. https://doi.org/10.18632/oncotarget.9728

Chicago

Hu, Minghua, Mingwei Wang, Huihong Lu, Xiaoming Wang, Xiaoshan Fang, Jinguo Wang, Chenyang Ma, Xiaobing Chen, and Hongping Xia. 2016. “Loss of MiR-1258 Contributes to Carcinogenesis and Progression of Liver Cancer through Targeting CDC28 Protein Kinase Regulatory Subunit 1B.” Oncotarget 7 (28): 43419–31. doi:10.18632/oncotarget.9728.